Project Details
Projekt Print View

Development of preferential HDAC6 inhibitors and degraders to immunosensitize myeloid leukemia cells

Subject Area Pharmacy
Term since 2026
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 574430877
 
No abstract available
DFG Programme Research Grants
International Connection USA
 
 

Additional Information

Textvergrößerung und Kontrastanpassung